V565

DRUG3 trials

Sponsors

VHsquared Ltd.

Conditions

Crohn's DiseaseUlcerative Colitis

Phase 1

A First Time in Human Study in Healthy Volunteers and Patients

CompletedNCT03010787

VHsquared Ltd.Crohn's Disease

Start: 2015-09-30End: 2016-03-31Updated: 2017-01-05

Open-label V565 Target Engagement Study

CompletedNCT03705117

VHsquared Ltd.Ulcerative Colitis

Start: 2017-05-23End: 2017-10-24Updated: 2018-10-15

Phase 2

A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease

CompletedNCT02976129

VHsquared Ltd.Crohn's Disease

Start: 2016-12-31End: 2019-03-08Updated: 2021-12-22